6.ALPHA.,7.ALPHA.-DIFLUOROMETHYLENE-11.BETA.,17.ALPHA.,21-TRIHYDROXY-16.ALPHA.-METHYLPREGN-4-EN-20-ONE-(3,2-C)-2'-P-FLUOROPHENYLPYRAZOLE
UNII FS6WG6PMW2
Substance Identification & Data
This profile provides standardized clinical and technical data for 6.alpha.,7.alpha.-difluoromethylene-11.beta.,17.alpha.,21-trihydroxy-16.alpha.-methylpregn-4-en-20-one-(3,2-c)-2'-p-fluorophenylpyrazole, uniquely identified by the FDA Unique Ingredient Identifier (UNII) FS6WG6PMW2.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 17720-56-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C30H33F3N2O4 JAAQUAGKUKUOCX-QAWZITTNSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 6.alpha.,7.alpha.-difluoromethylene-11.beta.,17.alpha.,21-trihydroxy-16.alpha.-methylpregn-4-en-20-one-(3,2-c)-2'-p-fluorophenylpyrazole. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.